Safety of non-vitamin K antagonist oral anticoagulants: concerns in patients with atrial fibrillation and glomerular hyperfiltration?

被引:6
|
作者
Huqi, Alda [1 ,2 ]
Zoccali, Carmine [3 ,4 ]
Giugliano, Robert P. [5 ]
De Caterina, Raffaele [1 ,2 ,6 ]
机构
[1] Univ Pisa, Chair Cardiol, Via Paradisa 2, I-56124 Pisa, Italy
[2] Pisa Univ Hosp, Cardiol Div, Via Paradisa 2, I-56124 Pisa, Italy
[3] Renal Res Inst, New York, NY USA
[4] Osped Riuniti Reggio Calabria, Nefrol CNR, Assoc Ipertens Nefrol Trapianto Renale IPNET, Reggio Di Calabria, Italy
[5] Harvard Med Sch, Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA
[6] Fdn VillaSerena Ric, Pescara, Italy
关键词
LINE RENAL-FUNCTION; WARFARIN; EDOXABAN; DABIGATRAN; STROKE; TRIAL;
D O I
10.1093/eurheartj/ehac450
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:322 / 325
页数:4
相关论文
共 50 条
  • [21] Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants
    Susin Park
    Nam Kyung Je
    International Journal of Arrhythmia, 23 (1)
  • [22] How safe are non-vitamin K antagonist oral anticoagulants in atrial fibrillation?
    De Caterina, Raffaele
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2016, 18 (0I) : 1 - 6
  • [23] Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in low-weight patients with atrial fibrillation
    Chen, Kuan-Hsuan
    Hsu, Yeh-Yun
    Chou, Chian-Ying
    Hsu, Chia-Chen
    Chang, Shih-Lin
    Yu, Wen-Chung
    Chang, Yuh-Lih
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2024, 57 (07) : 1268 - 1280
  • [24] Effectiveness and safety of non-vitamin k antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease
    Moon, I. K.
    Lee, S. R.
    Choi, E. K.
    Lee, E. J.
    Jung, J. H.
    Han, K. D.
    Cha, M. J.
    Oh, S. I.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2019, 40 : 2984 - 2984
  • [25] Real-world efficacy and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
    Violi, Francesco
    Pastori, Daniele
    INTERNAL AND EMERGENCY MEDICINE, 2019, 14 (08) : 1199 - 1201
  • [26] Real-world efficacy and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
    Francesco Violi
    Daniele Pastori
    Internal and Emergency Medicine, 2019, 14 : 1199 - 1201
  • [27] Changes in renal function in patients with atrial fibrillation: Efficacy and safety of the non-vitamin K antagonist oral anticoagulants
    Miyazawa, Kazuo
    Pastori, Daniele
    Lip, Gregory Y. H.
    AMERICAN HEART JOURNAL, 2018, 198 : 166 - 168
  • [28] Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in octogenarian patients with non-valvular atrial fibrillation
    Kim, Hyue Mee
    Choi, Eue-Keun
    Park, Chan Soon
    Cha, Myung-Jin
    Lee, Seo-Young
    Kwon, Joon-Myung
    Oh, Seil
    PLOS ONE, 2019, 14 (03):
  • [29] Efficacy and safety of non-vitamin K oral anticoagulants in patients with atrial fibrillation and cancer
    Cavallari, I.
    Verolino, G.
    Patti, G.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1849 - 1849
  • [30] Low-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
    Lee, Ki Hong
    Park, Hyung Wook
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2023, 38 (05): : 583 - 594